EN DE
Watch DAVION HEALTHCARE PLC for free: we tell you when fair value or trend changes.
Data-driven stock valuation

DAVION HEALTHCARE PLC (DAVI) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of DAVION HEALTHCARE PLC stock $0.89, price $1.58, that is 43.7% below the price, quality 46 out of 100. Rating: strongly overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US · Based in Ireland

DH DAVION HEALTHCARE PLC logo Thin data Nov 10, 2026

DAVION HEALTHCARE PLC

DAVI · US
Weakest Setup

Our calculation puts a fair price 44% below what the stock costs today.

Quality 46/100
Fair value $0.8900 · Strongly overvalued
Negative free cash flow
Trails peers (0/6)
Thin data
Estimate
Watch DAVION HEALTHCARE PLC for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$11.65 $1.31 Fair Value $0.8900 Oct 2026 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

1‑month range $1.31 – $11.65 · fair‑value band $0.6700 – $1.11 · the $1.58 price screens above the $0.8900 fair value. As of Nov 10, 2026.

Follow DAVION HEALTHCARE in your weekly email

Every Wednesday you see whether DAVION HEALTHCARE is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Davion Healthcare Plc, a digital healthcare company, engages in the design, development, and commercialization of non-invasive health monitoring technologies.

Show moreShow less

Its core consumer health portfolio comprises proprietary, home-based monitoring devices designed to support the early identification of potential medical anomalies.

The company's flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature.

It is also developing a portfolio of proprietary health monitoring technologies, including FootFlow for monitoring indicators associated with circulation and diabetes-related blood flow issues; Testic, an at-home testicular health monitoring system; and ThermaDerm for the identification of skin anomalies, as well as technologies addressing wound monitoring, blood pressure, and other areas of preventive healthcare.

The company was incorporated in 2022 and is based in Cork, Ireland.

Stock analysis

DAVION HEALTHCARE PLC (DAVI) currently trades at $1.58, while our estimate is $0.8900, 44% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: $0.6700 (bear) to $1.11 (bull), the price of $1.58 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 46/100 (below-average quality), in the Healthcare sector.

DAVION HEALTHCARE PLC reported revenue of €0 in FY2025 versus €0 in FY2023. Reported net income was −€1.1M in FY2025.

Key figures

Market cap $150M Micro · EPS (TTM) $−0.0500 · Return on assets (EBIT) −40.6% (3-year average) · Free cash flow −€323.

What moves the price

For context, the median of 10 Healthcare peers we cover trades at −45% fair-value upside, at −44%, DAVI screens cheaper than that median.

Fair Value

Bear $0.6700 Fair Value $0.8900 Bull $1.11
Price $1.58 · Downside -43.7%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 46/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 0
How much profit the company makes from its sales and capital
Quality Growth 75
Are margins and returns getting better?
Cashflow 50
Do the profits arrive as real cash?
Financial strength 72
Debt, balance sheet and risk of trouble
Investment 0
Does it invest with discipline instead of growing at any price?
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
not computed

DAVI screens overvalued: fair value 44% below the price. Compare with Intuitive Surgical, Inc →

Compare DAVION HEALTHCARE PLC with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 196 stocks

Beats the industry median on 0/5 measures
Overall it trails its industry peers.
Valuation
Quality Score 46 · Below median
Fair Value upside −43.7% · Bottom 25%
Profitability
Return on assets −48.6% · Bottom 25%
Operating margin (12 months) 0.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 0.0% · Below median

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Solventum Corporation SOLV $90.08 $131.27 +46% vs DAVI
EssilorLuxottica Société anonyme EL €187.60 €196.22 +5% vs DAVI
Intuitive Surgical, Inc ISRG $450.04 $353.90 −21% vs DAVI
Medline Inc MDLN $40.91 $28.59 −30% vs DAVI
Alcon Inc ALC CHF 61.88 CHF 34.06 −45% vs DAVI
Becton, Dickinson and Company BDX $212.61 $97.80 −54% vs DAVI
Straumann Holding STMN CHF 106.85 CHF 45.50 −57% vs DAVI
West Pharmaceutical Services, Inc WST $412.55 $139.22 −66% vs DAVI
Sartorius Stedim Biotech S.A DIM €223.40 €54.82 −75% vs DAVI
Sartorius Aktiengesellschaft SRT €227.00 €42.50 −81% vs DAVI

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

DAVION HEALTHCARE PLC: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "DAVION HEALTHCARE PLC Fair Value". https://www.fairvalue-calculator.com/stock/DAVI

Frequently asked questions

Is DAVION HEALTHCARE PLC (DAVI) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is $0.8900 versus a price of $1.58, about 44% lower (overvalued).
What is the fair value of DAVI?
Our estimate for DAVION HEALTHCARE PLC is $0.8900 (as of Nov 10, 2026), built from audited fundamentals. The current price: $1.58.
What is the quality score of DAVI?
DAVION HEALTHCARE PLC has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for DAVION HEALTHCARE PLC (DAVI)?
Our calculated price target is the estimate of $0.8900 (as of Nov 10, 2026). Cautious scenario $0.6700, optimistic scenario $1.11. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the DAVION HEALTHCARE PLC stock forecast for 2026?
Our estimate puts fair value at $0.8900, about 44% lower versus a price of $1.58 (overvalued). Cautious scenario $0.6700, optimistic scenario $1.11. The calculation is refreshed regularly with new filings.
What is the intrinsic value of DAVION HEALTHCARE PLC (DAVI)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For DAVION HEALTHCARE PLC it is $0.8900 per share (as of Nov 10, 2026), against a price of $1.58.
Is DAVION HEALTHCARE PLC stock overvalued or undervalued in 2026?
As of Nov 10, 2026, DAVI trades above its calculated fair value: price $1.58, fair value $0.8900, a gap of about −44% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of DAVI?
No. The price is what the market pays today ($1.58); the fair value is what the company's own numbers justify ($0.8900). For DAVION HEALTHCARE PLC the two are $0.6900 per share apart. That gap is exactly why we show both numbers side by side.
How much is DAVION HEALTHCARE PLC worth?
The market values DAVION HEALTHCARE PLC at about $150M (market capitalisation, as of Nov 10, 2026). Per share that is $1.58; our models calculate a fair value of $0.8900 per share.
What do the bullish and bearish scenarios say about DAVI?
Our models span a range for DAVION HEALTHCARE PLC: cautious scenario $0.6700, base $0.8900, optimistic $1.11 per share (as of Nov 10, 2026, price $1.58). The range comes from different growth and margin assumptions, not from analyst opinions.
Which stocks are comparable to DAVION HEALTHCARE PLC?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Becton, Dickinson and Company, Medline Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is DAVION HEALTHCARE PLC stock attractive at the current price?
The data as of Nov 10, 2026: price $1.58, calculated fair value $0.8900 (−44%), Quality Score 46/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. DAVION HEALTHCARE PLC itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of DAVION HEALTHCARE PLC (DAVI)?
The closing price on Nov 10, 2026 was $1.58. Our estimate is $0.8900, about 44% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with DAVION HEALTHCARE PLC right now?
The price sits above even our optimistic bull case ($1.11). The favourable scenario is already priced in. Weak quality (46/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of DAVION HEALTHCARE PLC

How large is the market capitalisation of DAVION HEALTHCARE PLC (DAVI)?
The market capitalisation of DAVION HEALTHCARE PLC is $150M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of DAVION HEALTHCARE PLC (DAVI)?
Earnings per share at DAVION HEALTHCARE PLC are $−0.0500. Earnings per share over the last twelve months: total profit spread across every single share.
What is the EBIT return on assets of DAVION HEALTHCARE PLC (DAVI)?
On an EBIT basis the return on assets of DAVION HEALTHCARE PLC is −40.6% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much free cash flow does DAVION HEALTHCARE PLC (DAVI) generate?
The free cash flow of DAVION HEALTHCARE PLC is −€323 (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch DAVION HEALTHCARE PLC in the live analysis

One click puts DAVION HEALTHCARE PLC on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.